High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis

AS Gabet, F Mortreux, A Talarmin, Y Plumelle, A Leroy… - Oncogene, 2000 - nature.com
AS Gabet, F Mortreux, A Talarmin, Y Plumelle, A Leroy, A Gessain, E Clity, M Joubert…
Oncogene, 2000nature.com
Adult T cell leukemia (ATLL) develops in 3–5% of HTLV-1 carriers after a long period of
latency during which a persistent polyclonal expansion of HTLV-1 infected lymphocytes is
observed in all individuals. This incubation period is significantly shortened in HTLV-1
carrier with Strongyloides stercoralis (Ss) infection, suggesting that Ss could be a cofactor of
ATLL. As an increased T cell proliferation at the asymptomatic stage of HTLV-1 infection
could increase the risk of malignant transformation, the effect of Ss infection on infected T …
Abstract
Adult T cell leukemia (ATLL) develops in 3–5% of HTLV-1 carriers after a long period of latency during which a persistent polyclonal expansion of HTLV-1 infected lymphocytes is observed in all individuals. This incubation period is significantly shortened in HTLV-1 carrier with Strongyloides stercoralis (Ss) infection, suggesting that Ss could be a cofactor of ATLL. As an increased T cell proliferation at the asymptomatic stage of HTLV-1 infection could increase the risk of malignant transformation, the effect of Ss infection on infected T lymphocytes was assessed in vivo in HTLV-1 asymptomatic carriers. After real-time quantitative PCR, the mean circulating HTLV-1 proviral load was more than five times higher in HTLV-1 carriers with stongyloidiasis than in HTLV-1+ individuals without Ss infection (P< 0.009). This increased proviral load was found to result from the extensive proliferation of a restricted number of infected clones, ie from oligoclonal expansion, as evidenced by the semiquantitative amplification of HTLV-1 flanking sequences. The positive effect of Ss on clonal expansion was reversible under effective treatment of strongyloidiasis in one patient with parasitological cure whereas no significant modification of the HTLV-1 replication pattern was observed in an additional case with strongyloidiasis treatment failure. Therefore, Ss stimulates the oligoclonal proliferation of HTLV-1 infected cells in HTLV-1 asymptomatic carriers in vivo. This is thought to account for the shortened period of latency observed in ATLL patients with strongyloidiasis.
nature.com